Clinical Experience With an L-Proline–Stabilized 10 % Intravenous Immunoglobulin (Privigen®): Real-Life Effectiveness and Tolerability

PURPOSE: This retrospective study evaluated the effectiveness and tolerability in clinical practice of an L-proline–stabilized 10 % intravenous immunoglobulin (IVIG; Privigen®) in patients with primary (PID) or secondary immunodeficiency (SID). METHODS: Patients from 6 centers in Europe and the US w...

Descripción completa

Detalles Bibliográficos
Autores principales: Dorsey, Morna J., Ho, Viet, Mabudian, Mohsen, Soler-Palacín, Pere, Domínguez-Pinilla, Nerea, Rishi, Radha, Rishi, Rahul, Wong, Duane, Rojavin, Mikhail, Hubsch, Alphonse, Berger, Melvin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165870/
https://www.ncbi.nlm.nih.gov/pubmed/24981039
http://dx.doi.org/10.1007/s10875-014-0070-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165870/
https://www.ncbi.nlm.nih.gov/pubmed/24981039
http://dx.doi.org/10.1007/s10875-014-0070-z

Ejemplares similares